BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23319307)

  • 1. Human antibodies reactive to NeuGcGM3 ganglioside have cytotoxic antitumor properties.
    Rodríguez-Zhurbenko N; Martínez D; Blanco R; Rondón T; Griñán T; Hernández AM
    Eur J Immunol; 2013 Mar; 43(3):826-37. PubMed ID: 23319307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-NeuGcGM3 antibodies, actively elicited by idiotypic vaccination in nonsmall cell lung cancer patients, induce tumor cell death by an oncosis-like mechanism.
    Hernández AM; Rodríguez N; González JE; Reyes E; Rondón T; Griñán T; Macías A; Alfonso S; Vázquez AM; Pérez R
    J Immunol; 2011 Mar; 186(6):3735-44. PubMed ID: 21300821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-NeuGcGM3 reactivity: a possible role of natural antibodies and B-1 cells in tumor immunosurveillance.
    Rodriguez-Zhurbenko N; Rabade-Chediak M; Martinez D; Griñan T; Hernandez AM
    Ann N Y Acad Sci; 2015 Dec; 1362():224-38. PubMed ID: 26214505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the antibody response against NeuGcGM3 ganglioside elicited in non-small cell lung cancer patients immunized with an anti-idiotype antibody.
    Hernández AM; Toledo D; Martínez D; Griñán T; Brito V; Macías A; Alfonso S; Rondón T; Suárez E; Vázquez AM; Pérez R
    J Immunol; 2008 Nov; 181(9):6625-34. PubMed ID: 18941253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients.
    Segatori VI; Cuello HA; Gulino CA; Albertó M; Venier C; Guthmann MD; Demarco IA; Alonso DF; Gabri MR
    Cancer Immunol Immunother; 2018 Aug; 67(8):1285-1296. PubMed ID: 29936534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Glycolyl GM3 ganglioside immunoexpression in oral mucosal melanomas of Chinese.
    Zhong Y; Wu Y; Li C; Tang J; Wang X; Ren G; Carr A; Pérez R; Guo W
    Oral Dis; 2012 Nov; 18(8):741-7. PubMed ID: 22574836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine.
    Carr A; Rodríguez E; Arango Mdel C; Camacho R; Osorio M; Gabri M; Carrillo G; Valdés Z; Bebelagua Y; Pérez R; Fernández LE
    J Clin Oncol; 2003 Mar; 21(6):1015-21. PubMed ID: 12637465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study.
    Osorio M; Gracia E; Rodríguez E; Saurez G; Arango Mdel C; Noris E; Torriella A; Joan A; Gómez E; Anasagasti L; González JL; Melgares Mde L; Torres I; González J; Alonso D; Rengifo E; Carr A; Pérez R; Fernández LE
    Cancer Biol Ther; 2008 Apr; 7(4):488-95. PubMed ID: 18285705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic Response Elicited in Breast Cancer Patients Receiving a NeuGcGM3-based Vaccine as Adjuvant Therapy.
    Valdes-Zayas A; Gonzalez Z; Mulens V; Vega AM; Perez K; Lorenzo-Luaces P; Rubio MC; Estevez A; Curbelo I; Fernandez LE; Crombet T; Mazorra Z
    J Immunother; 2017 Oct; 40(8):289-301. PubMed ID: 28604556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching on cytotoxicity by a single mutation at the heavy chain variable region of an anti-ganglioside antibody.
    Fernández-Marrero Y; Hernández T; Roque-Navarro L; Talavera A; Moreno E; Griñán T; Vázquez AM; de Acosta CM; Pérez R; López-Requena A
    Mol Immunol; 2011 Apr; 48(8):1059-67. PubMed ID: 21306777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cytotoxic humanized anti-ganglioside antibody produced in a murine cell line defective of N-glycolylated-glycoconjugates.
    Fernández-Marrero Y; Roque-Navarro L; Hernández T; Dorvignit D; Molina-Pérez M; González A; Sosa K; López-Requena A; Pérez R; de Acosta CM
    Immunobiology; 2011 Dec; 216(12):1239-47. PubMed ID: 21802167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
    Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies.
    Kusano A; Ohta S; Shitara K; Hanai N
    Anticancer Res; 1993; 13(6A):2207-12. PubMed ID: 8297135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it's potential therapeutic implications.
    Palomo AG; Santana RB; Pérez XE; Santana DB; Gabri MR; Monzon KL; Pérez AC
    Clin Exp Metastasis; 2016 Oct; 33(7):717-25. PubMed ID: 27449755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor and cytotoxic properties of a humanized antibody specific for the GM3(Neu5Gc) ganglioside.
    Dorvignit D; García-Martínez L; Rossin A; Sosa K; Viera J; Hernández T; Mateo C; Hueber AO; Mesa C; López-Requena A
    Immunobiology; 2015 Dec; 220(12):1343-50. PubMed ID: 26224247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplified ELISA to detect autoantibodies to N-glycolyl-GM3 ganglioside.
    Iznaga N; Carr A; Fernández LE; Solozabal J; Núñez G; Perdomo Y; Morales A
    J Clin Lab Immunol; 1996; 48(2):75-85. PubMed ID: 16296265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic activity against human neuroblastoma and melanoma cells mediated by IgM antibodies derived from peripheral blood of healthy donors.
    Devarapu SK; Mamidi S; Plöger F; Dill O; Blixt O; Kirschfink M; Schwartz-Albiez R
    Int J Cancer; 2016 Jun; 138(12):2963-73. PubMed ID: 26830059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racotumomab-alum vaccine for the treatment of non-small-cell lung cancer.
    Hernández AM; Vázquez AM
    Expert Rev Vaccines; 2015 Jan; 14(1):9-20. PubMed ID: 25420897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies.
    Zhang G; Lopez PH; Li CY; Mehta NR; Griffin JW; Schnaar RL; Sheikh KA
    Brain; 2004 May; 127(Pt 5):1085-100. PubMed ID: 14985267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.